Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Kinsale Capital Group, Inc. Reports 2025 Fourth Quarter and Year-End Results
-
MNTN to Participate in Upcoming Investor Conferences
-
PureCycle Schedules Fourth Quarter and Fiscal Year Ending 2025 Corporate Update
-
Amkor Technology Announces Secondary Offering of 10 Million Shares of Common Stock by the Kim Family
-
Coinbase Delivers on Q4 Financial Outlook, Doubles Total Trading Volume and Crypto Trading Volume Market Share in 2025
-
Instacart Announces Fourth Quarter and Full Year 2025 Financial Results
-
Mach Natural Resources LP Announces Earnings Release and Conference Call Schedule for Fourth Quarter and Full Year 2025
-
Ontario’s Plan for Long-Term Sustainability in Post-Secondary Education: Students Welcome Funding But The Ministry Misses the Mark on Affordability
-
Debevoise Makes Significant Investments in Restructuring Capabilities with Partner Hires and Leadership Appointments
-
Puma Biotechnology to Host Conference Call to Discuss Fourth Quarter and Full Year 2025 Financial Results
-
CCS Fundraising Releases Fifth Annual Philanthropy Pulse Report on the Forces Shaping Nonprofit Fundraising in 2026
-
SPS Commerce Appoints New Independent Directors to the Board
-
Envoy Medical Announces Closing of Up to $78.0 Million Upsized Public Offering
-
Trupanion Reports Fourth Quarter & Full Year 2025 Results
-
Pinterest Announces Fourth Quarter and Full Year 2025 Results, Delivers 14% Revenue Growth and Record Users
-
Nu Skin Enterprises Reports Fourth Quarter and Full-year 2025 Results Within Guidance
-
Aurora to Ring the Nasdaq Closing Bell on Wednesday, February 18, 2026, Reinforcing Strategic Focus on Global Medical Cannabis
-
Meta Announces Quarterly Cash Dividend
-
HASI Announces Fourth Quarter and Full Year 2025 Results with New Investments up 87% Y/Y to a Record $4.3b, Adjusted ROE up 70 bps to 13.4% and Adjusted EPS up 10% to $2.70
-
Procore Announces Fourth Quarter and Full Year 2025 Financial Results
-
BioMarin Announces Closing of Private Offering of Senior Notes
-
Twilio Announces Fourth Quarter and Full Year 2025 Results
-
Sensus Healthcare Reports Fourth Quarter 2025 Financial Results Highlighted by Publication of Dedicated CPT Codes for SRT to Treat Non-Melanoma Skin Cancer
-
Dutch Bros Inc. Reports Fourth Quarter and Fiscal Year 2025 Financial Results
-
JFrog Announces Fourth Quarter and Fiscal 2025 Results
-
Fortune Brands Innovations Announces Fourth Quarter and Full-Year 2025 Results
-
Grindr Announces Date of Fourth Quarter and Full Year 2025 Financial Results Earnings Call
-
Yelp Delivers Record Net Revenue in 2025 Accelerating Investment in AI Transformation
-
EVERTEC to Announce Fourth Quarter 2025 Financial Results on February 26, 2026
-
Mach Natural Resources LP Declares Fourth Quarter 2025 Cash Distribution of $0.53 Per Common Unit
-
Federal Realty Investment Trust Reports Fourth Quarter and Full Year 2025 Results
-
Toast Announces Fourth Quarter and Full Year 2025 Financial Results
-
Xponential Fitness, Inc. to Announce Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 26th
-
REPAY Announces Departure of Co-Founder and President Shaler Alias
-
Arista Networks, Inc. Reports Fourth Quarter and Year End 2025 Financial Results
-
Ryan Specialty Reports Fourth Quarter 2025 Results
-
Fortune Brands Innovations Appoints Amit Banati as CEO
-
Olin to Take a Fourth Quarter 2025 Charge Following Verdict in Shintech v. Olin Litigation
-
PacBio Announces Fourth Quarter and Full Year 2025 Financial Results
-
Public Storage Announces PS4.0™ — A New Era of Leadership, Growth and Value Creation
-
FLOWERS FOODS, INC. REPORTS FOURTH QUARTER AND FULL YEAR 2025 RESULTS
-
Warrior Reports Fourth Quarter and Full Year 2025 Results
-
BILL to Participate in Upcoming Investor Conferences
-
Celcuity Appoints Charles Romp to its Board of Directors
-
Sabra Reports Fourth Quarter 2025 Results; Introduces 2026 Guidance
-
Caribou Biosciences to Participate in Upcoming Investor Conferences
-
Research Solutions Reports Second Quarter Fiscal Year 2026 Results
-
Vasa Therapeutics Announces Participation at the 36th Annual Oppenheimer Life Sciences Conference
-
Forrester Research Reports 2025 Fourth-Quarter And Full-Year Financial Results
-
10x Genomics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Outlook for 2026
